Asimov launches AAV Edge, a suite of AI models, host cells, and genetic tools for end-to-end gene therapy development

  • Post author:
  • Post category:uncategorized

Asimov, the synthetic biology company advancing the design and production of therapeutics, today announced the launch of the AAV Edge System, a comprehensive suite of tools for adeno-associated viral (AAV) gene therapy design and manufacturing.